Detailed Quote:IPIX .. hmmm 3M in *volume* .. ;) .. go

New Post Public Reply Private Reply Replies (2) Message Board
4kids 4kids #66879
666
Detailed Quote:IPIX .. hmmm 3M in *volume* .. .. go figure
INNOVATION PHARMACEUTICALS INC
0.21395Up 0.01305 (6.495769 %) AS OF 3:59:54PM ET 10/30/2020

Price Performance (Last 52 Weeks)
10/29/2020 +96.19%


Volume 3,043,127
Volume (10 day Average) 643,583
Volume (90 day Average) 2,020,874


Market Capitalization $69.75M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2009Down -0.00235 (-1.156212 %) AS OF 3:58:56PM ET 10/29/2020

Price Performance (Last 52 Weeks)
10/28/2020 +109.64%


Volume 308,501
Volume (10 day Average) 655,273
Volume (90 day Average) 2,159,197


Market Capitalization $70.57M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.20325Up 0.00025 (0.123153 %) AS OF 3:58:51PM ET 10/28/2020

Price Performance (Last 52 Weeks)
10/27/2020 +105.05%


Volume 681,887
Volume (10 day Average) 648,470
Volume (90 day Average) 2,239,547


Market Capitalization $70.48M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.203Up 0.0009 (0.445324 %) AS OF 3:51:28PM ET 10/27/2020

Price Performance (Last 52 Weeks)
10/26/2020 +104.14%


Volume 412,936
Volume (10 day Average) 681,887
Volume (90 day Average) 2,407,341


Market Capitalization $70.17M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2021Up 0.002 (0.9995 %) AS OF 3:52:53PM ET 10/26/2020

Price Performance (Last 52 Weeks)
10/23/2020 +105.23%


Volume 775,850
Volume (10 day Average) 793,424
Volume (90 day Average) 2,895,096


Market Capitalization $69.47M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2001Down -0.00424 (-2.074973 %) AS OF 3:54:20PM ET 10/23/2020

Price Performance (Last 52 Weeks)
10/22/2020 +115.09%


Volume 520,290
Volume (10 day Average) 793,424
Volume (90 day Average) 2,895,096


Market Capitalization $70.94M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.20434Down -0.00356 (-1.712362 %) AS OF 3:58:40PM ET 10/22/2020

Price Performance (Last 52 Weeks)
10/21/2020 +108.11%


Volume 714,079
Volume (10 day Average) 793,424
Volume (90 day Average) 2,895,096


Market Capitalization $72.18M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2079Up 0.0001 (0.048123 %) AS OF 3:56:57PM ET 10/21/2020

Price Performance (Last 52 Weeks)
10/20/2020 +108.01%


Volume 713,910
Volume (10 day Average) 820,815
Volume (90 day Average) 2,899,636


Market Capitalization $72.15M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2078Down -0.0001 (-0.0481 %) AS OF 3:43:57PM ET 10/20/2020

Price Performance (Last 52 Weeks)
10/19/2020 +108.11%


Volume 934,987
Volume (10 day Average) 820,815
Volume (90 day Average) 2,899,636


Market Capitalization $72.18M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2079Up 0.00115 (0.556227 %) AS OF 3:58:27PM ET 10/19/2020

Price Performance (Last 52 Weeks)
10/16/2020 +106.75%


Volume 539,619
Volume (10 day Average) 913,701
Volume (90 day Average) 2,923,802


Market Capitalization $71.78M
Shares Outstanding 347,186,000
===========================
Historical Short Volume Data for IPIX

 
Date Close High Low Volume Sht Vol % of Vol Shtd

Oct 30 NA NA NA 3,040,127 2,064,613 67.91% ******
Oct 29 NA NA NA 308,501 61,201 19.84% E
Oct 28 NA NA NA 681,887 236,825 34.73%
Oct 27 NA NA NA 412,936 98,758 23.92% D
Oct 23 NA NA NA 520,290 213,691 41.07%
Oct 22 NA NA NA 714,079 317,431 44.45%
Oct 21 NA NA NA 713,910 156,356 21.90% C
Oct 20 NA NA NA 934,987 557,842 59.66%
Oct 19 NA NA NA 539,619 233,863 43.34%
Oct 16 NA NA NA 833,773 404,599 48.53%

Oct 15 NA NA NA 425,401 146,077 34.34%
Oct 14 NA NA NA 613,853 234,971 38.28%
Oct 13 NA NA NA 737,108 350,044 47.49%
Oct 12 NA NA NA 578,288 234,444 40.54% B
Oct 09 NA NA NA 1,025,799 709,519 69.17%
Oct 08 NA NA NA 1,174,666 760,322 64.73%
Oct 07 NA NA NA 1,055,749 688,727 65.24%
Oct 06 NA NA NA 1,208,894 657,712 54.41%
Oct 05 NA NA NA 1,468,476 977,793 66.59%
Oct 02 NA NA NA 6,245,126 3,662,097 58.64%% *****
Oct 01 NA NA NA 663,935 247,471 37.27%

Sep 30 NA NA NA 475,784 313,022 65.79%
Sep 29 NA NA NA 1,046,776 482,802 46.12%
Sep 28 NA NA NA 889,558 424,164 47.68%
Sep 25 NA NA NA 1,986,343 760,038 38.26%
Sep 24 NA NA NA 1,119,577 253,095 22.61% A
Sep 23 NA NA NA 1,396,982 710,712 50.87%
Sep 22 NA NA NA 1,215,571 595,465 48.99%
Sep 21 NA NA NA 773,866 299,446 38.69%
Sep 18 NA NA NA 1,031,043 447,658 43.42%
Sep 17 NA NA NA 1,078,135 663,697 61.56%
Sep 16 NA NA NA 2,788,722 1,268,722 45.49%

Sep 15 NA NA NA 12,948,414 5,507,122 42.53% ****
Sep 14 NA NA NA 568,409 299,316 52.66%
Sep 11 NA NA NA 572,086 344,622 60.24%
Sep 10 NA NA NA 472,282 269,628 57.09%
Sep 09 NA NA NA 436,695 320,996 73.51%
Sep 08 NA NA NA 1,694,578 1,010,478 59.63% ***
Sep 04 NA NA NA 1,619,804 1,072,314 66.20%
Sep 03 NA NA NA 1,467,420 940,998 64.13%
Sep 02 NA NA NA 1,256,071 716,978 57.08%
Sep 01 NA NA NA 933,410 471,778 50.54%

Aug 31 NA NA NA 1,032,019 570,486 55.28%
Aug 28 NA NA NA 913,239 455,111 49.83%
Aug 27 NA NA NA 913,446 574,129 62.85%
Aug 26 NA NA NA 1,601,531 1,059,780 66.17% **
Aug 25 NA NA NA 1,398,358 759,317 54.30%
Aug 24 NA NA NA 6,015,802 3,187,537 52.99% *
Aug 21 NA NA NA 1,312,168 661,297 50.40%
Aug 20 NA NA NA 1,111,127 621,873 55.97%
Aug 19 NA NA NA 1,201,893 581,350 48.37%
Aug 18 NA NA NA 1,397,414 882,970 63.19%
Aug 17 NA NA NA 1,128,186 568,549 50.39%

Aug 14 NA NA NA 1,423,346 692,153 48.63%
Aug 13 NA NA NA 1,057,579 548,523 51.87%
Aug 12 NA NA NA 1,406,491 681,043 48.42%
Aug 11 NA NA NA 1,659,920 850,348 51.23%
Aug 10 NA NA NA 2,015,792 793,871 39.38%
Aug 07 NA NA NA 1,686,981 795,055 47.13%
Aug 06 NA NA NA 2,479,779 1,198,690 48.34%
Aug 05 NA NA NA 1,092,323 504,530 46.19%
Aug 04 NA NA NA 2,625,758 1,630,279 62.09%
Aug 03 NA NA NA 3,611,854 2,507,917 69.44%

Jul 31 NA NA NA 1,035,908 527,927 50.96%
Jul 30 NA NA NA 4,421,368 2,765,370 62.55%
Jul 29 NA NA NA 1,584,578 865,553 54.62%
Jul 28 NA NA NA 1,478,641 947,848 64.10%
Jul 27 NA NA NA 5,429,584 2,982,599 54.93%
Jul 24 NA NA NA 2,804,276 1,635,949 58.34%
Jul 23 NA NA NA 1,443,141 852,554 59.08%
Jul 22 NA NA NA 1,583,764 877,353 55.40%
Jul 21 NA NA NA 2,471,827 1,406,938 56.92%
Jul 20 NA NA NA 7,011,994 3,903,198 55.66%
Jul 17 NA NA NA 1,700,006 948,578 55.80%
Jul 16 NA NA NA 1,572,843 950,607 60.44%

Jul 15 NA NA NA 3,122,082 1,883,905 60.34%
Jul 14 NA NA NA 6,521,081 2,175,892 33.37%
Jul 13 NA NA NA 8,151,877 4,078,491 50.03%
Jul 10 NA NA NA 2,154,827 932,019 43.25%
Jul 09 NA NA NA 1,892,612 1,107,610 58.52%
Jul 08 NA NA NA 2,573,759 1,462,374 56.82%
Jul 07 NA NA NA 4,061,212 2,594,248 63.88%
Jul 06 NA NA NA 2,287,553 1,226,968 53.64%
Jul 02 NA NA NA 3,788,429 1,822,707 48.11%
Jul 01 NA NA NA 1,521,940 646,991 42.51%

Jun 30 NA NA NA 1,742,511 982,243 56.37%
Jun 29 NA NA NA 2,815,051 1,614,501 57.35%
Jun 26 NA NA NA 3,288,168 1,755,618 53.39%
Jun 25 NA NA NA 2,908,354 1,679,709 57.75%
Jun 24 NA NA NA 7,625,067 4,299,436 56.39%
Jun 23 NA NA NA 12,750,039 6,169,402 48.39%
Jun 22 NA NA NA 7,884,928 3,996,456 50.68%
Jun 19 NA NA NA 15,326,213 9,254,306 60.38%


******Innovation Pharmaceuticals and George Mason University Announce Public Release of Laboratory Testing Results Demonstrating Brilacidin’s COVID-19 Treatment Potential
GLOBENEWSWIRE – 7:30 AM ET 10/30/2020

*****Innovation Pharmaceuticals Announces Pre-IND Meeting Request Granted by FDA for the Study of Brilacidin for the Treatment of COVID-19
GLOBENEWSWIRE – 10:00 AM ET 10/02/2020

****Laboratory Testing of Brilacidin for COVID-19 in Combination with Remdesivir Reduces Viral Load by Nearly 100 Percent
GLOBENEWSWIRE – 9:00 AM ET 09/15/2020

***Innovation Pharmaceuticals Announces Publication of Independent Research on Kevetrin, the Company’s p53 Drug Candidate, in Oncology Reports
GLOBENEWSWIRE – 10:00 AM ET 09/08/2020

**Dr. William F. DeGrado, a Discoverer of Brilacidin, Joins Innovation Pharmaceuticals as Scientific Advisor
GLOBENEWSWIRE – 9:30 AM ET 08/26/2020

*COVID-19 Drug Candidate Brilacidin Achieves a Selectivity Index Among the Highest Reported, Exhibiting Potent Anti-SARS-CoV-2 Activity at Low Concentrations; Clinical Trial Forthcoming
GLOBENEWSWIRE – 8:00 AM ET 08/24/2020

Innovation Pharmaceuticals and U.S. Regional Biocontainment Laboratory Nearing Completion of Brilacidin Anti-SARS-CoV-2 (COVID-19) In Vitro Testing
GLOBENEWSWIRE – 8:00 AM ET 08/04/2020

Innovation Pharmaceuticals Grants Licensing Rights to Fox Chase Chemical Diversity Center, Inc. for Antifungal Technology
GLOBENEWSWIRE – 8:00 AM ET 07/22/2020

Innovation Pharmaceuticals’ Brilacidin Inhibits Novel Coronavirus (COVID-19) by Almost 90% at the Lowest Concentration Tested to Date in a Human Lung Cell Line
GLOBENEWSWIRE – 7:30 AM ET 07/20/2020

Innovation Pharmaceuticals – Clinical Trial Testing of Brilacidin Against SARS-CoV-2 (COVID-19) Targeted to Commence Q4 2020
GLOBENEWSWIRE – 8:00 AM ET 07/13/2020

In Vitro Testing of Innovation Pharmaceuticals’ Brilacidin for COVID-19 Shows Consistent Anti-SARS-CoV-2 Efficacy; Manufacturing Preparation Underway for COVID-19 Clinical Trial
GLOBENEWSWIRE – 8:00 AM ET 07/07/2020

Innovation Pharmaceuticals’ Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line
GLOBENEWSWIRE – 7:30 AM ET 06/17/2020


===============================


IPIX YTD *Volume* as of EO SEO 2020 ~ 524,227,725

IPIX *Volume* by month as *reported* to Finra 2020 .. Oct 2020 due in early Nov

 
SEP 2020 ~ 35,785,026 ** matches 2/2020
AUG 2020 ~ 37,279,662
JUL 2020 ~ 68,767,947
JUN 2020 ~ 116,020,124 *** highest in 2020 >> See Next Post <<
MAY 2020 ~ 51,886,542
APR 2020 ~ 78,324,274
MAR 2020 ~ 86,903,508
FEB 2020 ~ 35,015,032 ** matches 9/2020
JAN 2020 ~ 14,245,610 * lowest in 2020



as a reminder IPIX's YTD Volume in 2018 was 88M~
as a reminder NR (non retail) injected *volume* of approx 55M~ in last 4 mos of 2018 (PPS reset from 53c to 7c)
as a reminder iPIX's YTD Volume in 2019 was 124M~
as a reminder NR injected *volume* in May 2019 of approx 23M~ to negate AS
as a reminder IPIX's YTD Volume @ EO October 2019 was 94M~
as a reminder IPIX's YTD Volume @ EO September 2020 was 524M~


https://otce.finra.org/otce/marketStatistics/...hareVolume

NR is between a rock and a hard space re: IPIX (stock)

https://investorshangout.com/post/view?id=5703011

next post (cliff notes version) for IPIX *recent pattern change outs* (A/B/C/D/E)

*imo* always worth noting *changes to* .. 10/90 day avgs .. YOY%s and how NR has to *mark* re: DRS %S

Detailed Quote:IPIX .. last 2 trades .. Friday .. go off hidden (between B/A)
INNOVATION PHARMACEUTICALS INC
0.21395Up 0.01305 (6.495769 %) AS OF 3:59:54PM ET 10/30/2020

Last Trade 0.21395
Trade Time 3:59:54pm ET

Change 0.01305
% Change 6.495769%


Bid 0.2104

Ask 0.2175


Open 0.24
Day High 0.241 .. *liquidity* = .036c
Day Low 0.205
Previous Close
10/30/2020 0.21395

52-Week High
06/23/2020 0.65

52-Week Low
01/03/2020 0.05


Price Performance (Last 52 Weeks)
10/30/2020 +113.95%


Volume 3,043,127
Volume (10 day Average) 864,519
Volume (90 day Average) 1,969,863

Market Capitalization $74.28M
Shares Outstanding 347,186,000



as always best to all Innovation Pharma investors ..

4kids












Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Adcendo’s Early Sarcoma Data Earns a Careful Look

Updated Category News Views 71

Sarcoma data rarely gives anyone permission to pound the table, yet Adcendo’s first look at ADCE-D01 deserves more than a polite nod. In advanced soft tissue sarcoma, where patients have often run through the usual options and second-line response rates historically sit around 4% to 10%, a reported 30% objective response rate on the every-two-week schedule is...

Continue Reading
Birla Carbon's Rayong Bet Tightens Asian Supply Lines

Updated Category News Views 31

Rayong just became a much louder pin on Asia's industrial map. Birla Carbon has inaugurated a 120 kMT carbon black plant in Thailand, and the significance is bigger than a ribbon-cutting photo. This is a capacity-and-location move aimed squarely at the uncomfortable part of industrial supply chains: customers need material when they need it, not after it has spent weeks...

Continue Reading
Ajman Media Forum Puts Trust Ahead of AI Speed in 2026

Updated Category News Views 179

Algorithms may manufacture a flood of words, but they cannot inherit accountability. That was the sensible nerve running through Ajman Media Forum 2026, “The Signal,” inaugurated on November 19 by His Highness Sheikh Ammar bin Humaid Al Nuaimi, Crown Prince of Ajman and Chairman of the Executive Council. For all the fanfare that usually surrounds artificial...

Continue Reading
StoneX Selloff Puts Earnings Quality Under a Harsh Lens

Updated Category News Views 75

A revenue beat can turn downright useless when the profit line springs a leak. StoneX Group delivered operating revenue above expectations and record full-year results, then watched investors hammer the stock after fiscal fourth-quarter diluted earnings per share landed at $0.66. That was $0.15 below the roughly $0.81 consensus cited in the notice, and other estimates...

Continue Reading
Cineverse Sets Wolf Creek Return for March 19, 2027

Updated Category News Views 86

A sunburned serial killer is heading back to theaters, and Cineverse has finally put a date on it: March 19, 2027. WOLF CRE3K, formerly called Wolf Creek: Legacy, brings John Jarratt back as Mick Taylor for the third film in the Australian horror franchise. For NASDAQ:CNVS investors, this is not the kind of announcement that lets anyone pencil in revenue with a straight...

Continue Reading
Evotec’s Second IND Adds Proof to Its Glue Platform

Updated Category News Views 73

Two IND acceptances from one long-running alliance is not nothing, especially in a drug-discovery business where plenty of polished platform talk never makes it to the clinic. Evotec has cleared that modest but meaningful bar again with Bristol Myers Squibb: a second molecular-glue candidate has received FDA acceptance for an Investigational New Drug application. The...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 5

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
SOCi's MCP Push Makes Context the Product Moat Bigger

Updated Category News Views 46

Software agents without decent business context are just eager interns with access to the keyboard. SOCi’s November 19, 2026 announcement gets at that unglamorous truth: the company has made its Model Context Protocol server generally available and says its context layer now connects with more than 140 integrations. It is not a flashy new chatbot stunt. It is a bid to...

Continue Reading
Software-Defined Cars Put $310 Billion in Play by 2035

Updated Category News Views 111

Cars are becoming rolling computers, and that changes who gets paid. Market Growth Reports projects the software-defined vehicle market will rise from $56.94 billion to $310.46 billion by 2035, a 20.74% compound annual growth rate. That is a loud number, no question. Still, investors ought to treat any long-range market forecast like a map, not a mortgage deed. The...

Continue Reading
McDonald's Franchise Wage Suit Puts Compliance on Notice

Updated Category News Views 129

Payroll sloppiness can turn a cheap burger shift into an expensive courtroom problem fast. Zakay Law Group, APLC has filed a proposed class action in Alameda County Superior Court against a long list of McDonald's franchise-related entities, alleging workers were not paid all wages due under California law. The case, 26CV218760, is pending, not proven, and that...

Continue Reading

Top 5 Most Recently Viewed Articles

PI Strengthens U.S. Manufacturing with New Facility Opening

Updated Category News Views 277

PI Enhances U.S. Manufacturing Capabilities PI (Physik Instrumente) is making significant strides in its operations by expanding its manufacturing capabilities in the United States. This move, aimed at strengthening its customer support, comes as the company prepares to open a new production facility soon. The expansion is a strategic response to current trade challenges...

Continue Reading
Revolutionizing K-12 Education with RightFind Curriculum

Updated Category News Views 157

Introducing the RightFind Curriculum by CCC CCC, a leader in copyright innovation, has launched its newest solution: the RightFind Curriculum. This tool is designed to help integrate high-quality, copyrighted materials into K-12 educational settings. It specifically caters to educators, EdTech companies, and curriculum developers, making it easier to search for and use...

Continue Reading
Essential Tips for Homebuyers During Peak Season

Updated Category News Views 157

Essential Tips for Homebuyers During Peak Season Spring is often seen as the height of the homebuying season. Many buyers aim to purchase homes and settle in before the summer months, especially before the new school year approaches. To assist homebuyers in navigating this critical time, the Pennsylvania Association of Realtors has shared useful insights. The Importance...

Continue Reading
Wolfspeed Faces Securities Fraud Lawsuit: What Investors Should Know

Updated Category News Views 926

Wolfspeed, Inc. Under Securities Fraud Investigation As many investors navigate turmoil in the stock market, a recent development concerning Wolfspeed, Inc. is drawing significant attention. Block & Leviton has announced that a lawsuit for securities fraud has been filed against Wolfspeed, Inc. (WOLF) and several of its executives. For those who have experienced financial...

Continue Reading
Ero Copper Corp. Set to Announce Q3 Results This November

Updated Category News Views 210

Ero Copper Corp. Prepares for Q3 Financial Results Release VANCOUVER, British Columbia – Excitement is building for Ero Copper Corp. (TSX: ERO, NYSE: ERO) as the company is set to publish its operating and financial results for the third quarter of 2025 on November 4. This announcement will occur after the market closes, providing valuable insights into the company’s...

Continue Reading